Zhaoke Ophthalmology Ltd. (HK:6622)
:6622
Want to see HK:6622 full AI Analyst Report?
Total Valuation
Zhaoke Ophthalmology Ltd. has a market cap or net worth of HK$1.47B. The enterprise value is HK$265.85M.
Market CapHK$1.47B
Enterprise ValueHK$265.85M
Share Statistics
Zhaoke Ophthalmology Ltd. has 548,749,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding548,749,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zhaoke Ophthalmology Ltd.’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -14.09%.
Return on Equity (ROE)-0.13
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-14.09%
Return on Capital Employed (ROCE)-0.17
Revenue Per Employee105.94K
Profits Per Employee-710.82K
Employee Count294
Asset Turnover0.02
Inventory Turnover4.35
Valuation Ratios
The current PE Ratio of Zhaoke Ophthalmology Ltd. is ―. Zhaoke Ophthalmology Ltd.’s PEG ratio is 0.51.
PE Ratio―
PS Ratio46.69
PB Ratio0.92
Price to Fair Value0.92
Price to FCF-5.49
Price to Operating Cash Flow-12.83
PEG Ratio0.51
Income Statement
In the last 12 months, Zhaoke Ophthalmology Ltd. had revenue of 31.15M and earned -203.57M in profits. Earnings per share was -0.37.
Revenue31.15M
Gross Profit-32.57M
Operating Income-266.41M
Pretax Income-203.57M
Net Income-203.57M
EBITDA-215.45M
Earnings Per Share (EPS)-0.37
Cash Flow
In the last 12 months, operating cash flow was -99.05M and capital expenditures -910.69K, giving a free cash flow of -99.96M billion.
Operating Cash Flow-99.05M
Free Cash Flow-99.96M
Free Cash Flow per Share-0.18
Dividends & Yields
Zhaoke Ophthalmology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.58
52-Week Price Change10.33%
50-Day Moving Average3.03
200-Day Moving Average3.33
Relative Strength Index (RSI)29.83
Average Volume (3m)1.25M
Important Dates
Zhaoke Ophthalmology Ltd. upcoming earnings date is Aug 26, 2026, TBA (Confirmed).
Last Earnings DateMar 25, 2026
Next Earnings DateAug 26, 2026
Ex-Dividend Date―
Financial Position
Zhaoke Ophthalmology Ltd. as a current ratio of 4.18, with Debt / Equity ratio of 18.55%
Current Ratio4.18
Quick Ratio4.14
Debt to Market Cap0.19
Net Debt to EBITDA4.66
Interest Coverage Ratio-30.11
Taxes
In the past 12 months, Zhaoke Ophthalmology Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Zhaoke Ophthalmology Ltd. EV to EBITDA ratio is -2.09, with an EV/FCF ratio of -1.70.
EV to Sales14.46
EV to EBITDA-2.09
EV to Free Cash Flow-1.70
EV to Operating Cash Flow-1.73
Balance Sheet
Zhaoke Ophthalmology Ltd. has HK$1.30B in cash and marketable securities with HK$292.48M in debt, giving a net cash position of HK$1.01B billion.
Cash & Marketable SecuritiesHK$1.30B
Total DebtHK$292.48M
Net CashHK$1.01B
Net Cash Per ShareHK$1.83
Tangible Book Value Per ShareHK$2.18
Margins
Gross margin is -32.98%, with operating margin of -855.36%, and net profit margin of -653.60%.
Gross Margin-32.98%
Operating Margin-855.36%
Pretax Margin-653.60%
Net Profit Margin-653.60%
EBITDA Margin-691.72%
EBIT Margin-855.36%
Analyst Forecast
The average price target for Zhaoke Ophthalmology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-53.85%
EPS Growth Forecast12.23%